Elisa Francesconi

459 citations
7 papers · 185 indexed · h-index 5

Elisa Francesconi

7 papers receiving 180 citations

Peers

Elisa Francesconi
Comparison fields: 5 of 46
  • Cancer Research 54
  • Oncology 66
  • Immunology 48
  • Genetics 49
  • Endocrinology, Diabetes and Metabolism 28
Replace Lise‐Lotte Vedin with:
Lise‐Lotte Vedin Sweden
Sandrine Le Mée France
Diane Krill United States
Jeanine Traag United States
Jianyang Fu United States
M.L González Morales Spain
Cédric Cortijo Switzerland
Inamul Kabir United States
Anita Frijhoff Netherlands
Shunchao Yan China
Elisa Francesconi relative to Lise‐Lotte Vedin Sweden Lise‐Lotte Vedin's profile →
Citations per field
00.5×1.5×
Lise‐Lotte Vedin · 1×
Citations per year

Countries citing papers authored by Elisa Francesconi

Since Specialization
Citations

This map shows the geographic impact of Elisa Francesconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Francesconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Francesconi more than expected).

Fields of papers citing papers by Elisa Francesconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Francesconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Francesconi. The network helps show where Elisa Francesconi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elisa Francesconi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elisa Francesconi Line = papers co-authored together Elisa Francesconi links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 20208
2 20164
3 201423
4 20023
5 199941
6
Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
199992
7 198814

About Elisa Francesconi

Elisa Francesconi is a scholar working on Hematology, Oncology and Cancer Research, having authored 7 papers that have together received 185 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (2 papers), NF-κB Signaling Pathways (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Cancer therapeutics and mechanisms (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Cancer Research (54 citations), Oncology (66 citations) and Immunology (48 citations). Elisa Francesconi has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Matthieu Resche‐Rigon, Wim Vanden Berghe, Guy Haegeman, Karolien De Bosscher, C. Damais, Bernard Dugas, Marielle Chiron, Hélène Goulaouic, Nizar El-Murr and Christophe Henry. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026